ArticleRheumatology and therapy2020

Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study.

Peter H Schafer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.